Clinical Trial: Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Low Dose Versus Weight-based Intravenous Acyclovir for Herpes Simplex Virus Prophylaxis in the Neutropenic Patient

Brief Summary:

RATIONALE: Acyclovir may be effective in preventing herpes simplex virus infection in patients with neutropenia.

PURPOSE: This randomized phase III trial is studying the side effects of acyclovir and is comparing two doses of acyclovir in preventing herpes simplex virus infection in patients with neutropenia.